Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation
Table 4
Multivariate analysis overall survival and progression-free survival.
Variables at day 100 post-APBHSCT
Overall survival
Progression-free survival
HR
95% CI
HR
95% CI
Female versus male
0.74
0.28–1.87
0.9
Albumin ≥ 4
0.98
0.31–3.71
0.9
0.82
0.32–1.95
0.7
ALC ≥ 0.6 cells/µL
0.42
0.14–1.30
0.1
0.57
0.24–1.41
0.2
Hemoglobin < 10.5 g/dL
1.24
0.33–4.54
0.7
1.06
0.41–2.69
0.9
IPS ≥ 3
1.83
0.45–8.17
0.4
2.02
0.67–6.40
0.2
WBC > 15 cells/µL
1.28
0.32–4.78
0.7
1.30
0.47–3.65
0.6
Day 15 ALC ≥ 0.5 cells/µL
0.29
0.07–1.12
0.07
0.46
0.21–0.99
<0.05
Day 100 ALC ≥ 0.8 cells/µL
0.55
0.20–1.42
0.2
0.54
0.25–1.16
0.1
Day 100 AMC ≥ 0.63 cells/µL
1.83
0.71–4.91
0.2
1.65
0.65–4.23
0.3
Day 100 ALC/AMC ≥ 1.3
0.33
0.12–0.85
<0.02
0.37
0.18–0.72
<0.004
Abbreviations: ALC: absolute lymphocyte count; AMC: absolute monocyte count; IPS: international prognostic score; WBC: white blood cell count.
